Mori Tetsushi, Saito Fumiyo, Yoshino Tomoko, Takeyama Haruko, Matsunaga Tadashi
Department of Biotechnology, Tokyo University of Agriculture and Technology, Koganei, Tokyo 184-8588, Japan.
Biotechnol Bioeng. 2008 Apr 15;99(6):1453-61. doi: 10.1002/bit.21729.
Genomic recombination was performed in a genetically modified stable HeLa cell line, HeLa55, using a uniquely designed donor vector harboring an exchange cassette comprised of the human glucocorticoid receptor (hGR) gene, its response element, and a luciferase reporter gene, to generate stable hGRLuc clones. After screening for cassette insertion, the selected stable clone, hGRLuc-7, showed high integration stability of the exchange cassette over 20 passages with significantly high luciferase activity and fold inductions of up to 40- to 50-fold. In addition, the cells were evaluated with synthetic glucocorticoid, dexamethasone, and a reasonable EC(50) value of approximately 2.3 x 10(-9) M was obtained. Strong and weak agonists, non-responsive chemicals, and hGR antagonists were also evaluated in which the stable hGRLuc-7 clone showed both high sensitivity and selectivity. The technology presented in this work is simple and reproducible, and shows great potential for the future development of genetically modified stable cell systems which are applicable in both fundamental and application researches of nuclear receptors.
在一种经过基因改造的稳定HeLa细胞系HeLa55中进行基因组重组,使用一种独特设计的供体载体,该载体携带一个交换盒,其中包含人糖皮质激素受体(hGR)基因、其反应元件和一个荧光素酶报告基因,以生成稳定的hGRLuc克隆。在筛选盒式插入后,所选的稳定克隆hGRLuc-7在20代以上显示出交换盒的高整合稳定性,具有显著高的荧光素酶活性和高达40至50倍的诱导倍数。此外,用合成糖皮质激素地塞米松对细胞进行评估,获得了约2.3×10^(-9) M的合理半数有效浓度(EC(50))值。还评估了强效和弱效激动剂、无反应性化学物质以及hGR拮抗剂,稳定的hGRLuc-7克隆在其中表现出高敏感性和选择性。这项工作中提出的技术简单且可重复,对于适用于核受体基础研究和应用研究的基因改造稳定细胞系统的未来发展具有巨大潜力。